ArticleACS omega2025
Jellyfish Collagen Grafted with Hydroxybutyl Chitosan and Protocatechuic Acid Adhesive Sponge with Antibacterial Activity for Rapid Hemostasis.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Collagen from Salted Jellyfish (Gels (Basel, Switzerland) · 2026Article
- Isolation, Characterization and Biological Evaluation of Collagen fromMarine drugs · 2026Article
- Multifunctional copper-based metal-organic frameworks/chitosan derivative/exosome composite sponge for skin healing.iScience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural jellyfish collagen (JC) has garnered significant attention in the field of hemostasis due to its oceanic origin, nontoxicity, biodegradability, and absence of complications related to diseases and religious beliefs. However, the hemostatic performance of pure JC is limited by its poor stability, adhesion to wet tissue, and mechanical properties. We developed a novel (HJP) sponge comprising JC, protocatechuic acid (PA), and hydroxybutyl chitosan (HS) to enhance the application of JC in emergency hemostasis. This sponge exhibits antibacterial properties, good biocompatibility, wet tissue adhesion, and hemostatic capabilities. The HJP sponge demonstrates excellent thermal stability and mechanical strength (tensile strength: ∼106.6 kPa, compressive strength at 70% compressive strain: ∼1013.5 kPa) and strong wet tissue adhesion (∼117.1 kPa). Upon application to a wound, the HJP sponge rapidly forms a wound seal, achieving effective hemostasis through the synergistic action of PA and JC. The blood loss was also reduced to 0.105 g when compared to a commercial gelatin sponge. This JC-based sponge, with its multifaceted characteristics, holds significant promise for rapid hemostasis in clinical applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.